Logo (Actavis) 855 (Guanfacine Hydrochloride Extended-Release 4 mg)
Pill with imprint Logo (Actavis) 855 is Yellow, Elliptical / Oval and has been identified as Guanfacine hydrochloride extended-release 4 mg. It is supplied by Actavis Pharma, Inc..
Guanfacine is used in the treatment of adhd; high blood pressure; tourette's syndrome and belongs to the drug class antiadrenergic agents, centrally acting. There is no proven risk in humans during pregnancy. Guanfacine 4 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Logo (Actavis) 855
Guanfacine hydrochloride extended-release
- Imprint:
- Logo (Actavis) 855
- Strength:
- 4 mg
- Color:
- Yellow
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Antiadrenergic agents, centrally acting
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Actavis Pharma, Inc.
- National Drug Code (NDC):
- 00228-2855
More about guanfacine
- Guanfacine Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 197 Reviews
- Drug class: antiadrenergic agents, centrally acting
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
